Jounce Therapeutics Reports First Quarter 2018 Financial Results
09 mai 2018 06h30 HE
|
Jounce Therapeutics, Inc.
- Preliminary efficacy data from Phase 1/2 ICONIC trial to be presented as an oral presentation at the 2018 ASCO Annual Meeting - - Company to host conference call and webcast today at 8:00 AM ET - ...